Gloucestershire holistic healthcare business owner, Devi Sundar, shares how mindful breathing can enhance health and ...
It is also seeking to broaden its product range to cater for insomnia and chronic obstructive pulmonary disease (COPD) sufferers. ResMed chief executive Mick Farrell. ResMed chairman and chief ...
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...
The following is a summary of "Emergent Pericardial Window in a Patient with Sarcoidosis-like Interstitial Lung Disease, COPD ...
The following is a summary of “Vancomycin-resistant Enterococcus (VRE) Pneumonia in a Patient With Advanced Chronic ...
For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...
Hurricane Helene's massive rains and flooding is a major health and safety risk for residents exposed to potential ...
Zacks.com on MSN16h
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPDSanofi SNY and partner Regeneron REGN announced that the FDA has approved their blockbuster drug, Dupixent, for its sixth ...
The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...
In adults with undiagnosed respiratory symptoms, dyspnea impact was worse in those with PRISm vs undiagnosed asthma or COPD.
The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.
Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback